Evidence map›Paper›PMID 40018606›Full record

ArticleBMJ public health2024

Depressive symptom trajectories among general population during the COVID-19 pandemic in Iceland: a prospective cohort study (2020-2023).

Yue Wang, Arna Hauksdóttir, Edda Bjork Thordardottir, Fenfen Ge, Elísabet Unnur Gísladóttir, Jóhanna Jakobsdóttir, Kristjana Hrönn Ásbjörnsdóttir, Harpa Rúnarsdóttir, Anna Bára Unnarsdóttir, Ingibjörg Magnúsdóttir and 9 more

Abstract read
In one paragraph

Article in BMJ public health, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Yue WangCentre of Public Health Sciences, Faculty of Medicine, University of Iceland, Reykjavik, Iceland.ORCID 0000-0002-0349-5681
Arna HauksdóttirCentre of Public Health Sciences, Faculty of Medicine, University of Iceland, Reykjavik, Iceland.
Edda Bjork ThordardottirCentre of Public Health Sciences, Faculty of Medicine, University of Iceland, Reykjavik, Iceland.ORCID 0000-0003-3775-9611
Fenfen GeCentre of Public Health Sciences, Faculty of Medicine, University of Iceland, Reykjavik, Iceland.
Elísabet Unnur GísladóttirInstitute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.
Jóhanna JakobsdóttirCentre of Public Health Sciences, Faculty of Medicine, University of Iceland, Reykjavik, Iceland.
Kristjana Hrönn ÁsbjörnsdóttirCentre of Public Health Sciences, Faculty of Medicine, University of Iceland, Reykjavik, Iceland.ORCID 0000-0002-3263-3457
Harpa RúnarsdóttirCentre of Public Health Sciences, Faculty of Medicine, University of Iceland, Reykjavik, Iceland.
Anna Bára UnnarsdóttirCentre of Public Health Sciences, Faculty of Medicine, University of Iceland, Reykjavik, Iceland.
Ingibjörg MagnúsdóttirCentre of Public Health Sciences, Faculty of Medicine, University of Iceland, Reykjavik, Iceland.ORCID 0000-0002-1983-6049
Thorvardur Jon LoveFaculty of Medicine, University of Iceland, Reykjavik, Iceland.
Sigurdur Yngvi KristinssonFaculty of Medicine, University of Iceland, Reykjavik, Iceland.ORCID 0000-0002-4964-7476
Runolfur PalssonFaculty of Medicine, University of Iceland, Reykjavik, Iceland.
Helga ZoegaCentre of Public Health Sciences, Faculty of Medicine, University of Iceland, Reykjavik, Iceland.ORCID 0000-0003-0761-9028
Fang FangInstitute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.
Gunnar TómassonCentre of Public Health Sciences, Faculty of Medicine, University of Iceland, Reykjavik, Iceland.
Huan SongCentre of Public Health Sciences, Faculty of Medicine, University of Iceland, Reykjavik, Iceland.ORCID 0000-0003-3845-8079
Thor AspelundCentre of Public Health Sciences, Faculty of Medicine, University of Iceland, Reykjavik, Iceland.ORCID 0000-0002-7998-5433
Unnur ValdimarsdottirCentre of Public Health Sciences, Faculty of Medicine, University of Iceland, Reykjavik, Iceland.ORCID 0000-0001-5382-946X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: While changes in the prevalence of depressive symptoms during the COVID-19 pandemic have been described across populations, few studies have incorporated multidimensional variables to characterise the varying effects of the pandemic on the population's mental health. Methods: This cohort study included 6423 participants aged ≥18 years from the Icelandic COVID-19 National Resilience Cohort. Data on depressive symptoms and pandemic-related and non-pandemic-related factors were obtained during three pandemic assessment periods (baseline, follow-up wave 1 and follow-up wave 2; April 2020-December 2021), while health outcomes were obtained during the post-pandemic assessment period (follow-up wave 3; September 2022-February 2023). We used latent growth mixture models to identify variation in depressive symptom trajectories during the pandemic. We then used XGBoost models with 37 pandemic-related and non-pandemic-related factors to characterise these trajectories. Moreover, we performed linear regression to assess the association between the identified trajectories and post-pandemic health outcomes. Results: Of the included participants, we identified four depressive symptom trajectories, including consistently low (83.7%), consistently high (5.3%), initially high (5.1%) and late-onset high (5.9%) symptom trajectories. Individuals who exercised frequently (≥3 days/week) and enjoyed social and family support were more likely to experience a consistently low symptom trajectory. In contrast, individuals with a history of psychiatric disorders, women and young adults (18-39 years) were less likely to follow the consistently low symptom trajectory. Moreover, compared with the consistently low symptom trajectory, the other trajectories were associated with significantly higher levels of depressive, anxiety and somatic symptoms and cognitive problems during the post-pandemic period. Conclusions: Our results underscore the long-lasting impact of the COVID-19 pandemic on population mental health. Interventions focusing on exercise, social support and family support may mitigate the adverse mental health effects of future pandemics.

Indexed as

COVID-19Mental HealthPublic Healthtrends

Identifiers

PMID40018606
PMCPMC11816283

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.